Sign in
4

Changes in Ownership

BlossomHill Therapeutics, Inc. Filed Acc 0001840599-26-000003

Director acquired 578,524 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Agrawal Sundeep · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-10 Conversion : show line 1 in the form +578,524 578,524 I

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-08-06 Grant or award : show line 2 in the form Director Stock Option (Right to Buy) +23,904 23,904 D
2026-08-10 Conversion : show line 3 in the form Series B Preferred Stock −578,524 0 I
Loading xslF345X06/form4-08102026_100855.xml…